Marc Iskowitz interviews Indegene’s Jack Mycka, VP of enterprise medical solutions and emerging biotech at Indegene, for his take on developments that have reset the drug-price “chessboard.” For her policy update, Lecia Bushak recaps a Senate hearing on PBMs and explains why a federal judge’s ACA ruling has the White House playing defense. And Jack O’Brien explores the TikTok hype around “face taping,” an anti-aging experiment that may not be so benign. Music by Sixième Son.